Compare GOAI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOAI | BDSX |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | 3 | 334 |
| Industry | Computer Software: Programming Data Processing | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.5M | 143.2M |
| IPO Year | N/A | 2020 |
| Metric | GOAI | BDSX |
|---|---|---|
| Price | $3.40 | $14.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 69.4K | ★ 72.3K |
| Earning Date | 04-10-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $88,499,000.00 |
| Revenue This Year | N/A | $25.26 |
| Revenue Next Year | N/A | $19.15 |
| P/E Ratio | $18.31 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $2.75 | $0.26 |
| 52 Week High | $6.67 | $20.21 |
| Indicator | GOAI | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 53.23 |
| Support Level | $3.48 | $12.77 |
| Resistance Level | $4.36 | $16.38 |
| Average True Range (ATR) | 0.26 | 1.14 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 31.75 | 62.18 |
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.